KOSDAQ
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,966.71 |
Jan. 14, 2025 | USD 64.79 | 20.68% |
|
South Korea |
|
2 |
1,537.30 |
Jan. 14, 2025 | USD 17.02 | -2.20% |
|
South Korea |
|
3 |
327.08 |
Jan. 14, 2025 | USD 18.31 | -0.19% |
|
||
4 |
173.28 |
Jan. 14, 2025 | USD 11.61 | 3.35% |
|
South Korea |
|
5 |
145.32 |
Jan. 14, 2025 | USD 43.58 | 6.40% |
|
South Korea |
|
6 |
132.77 |
Jan. 14, 2025 | USD 3.87 | 0.92% |
|
South Korea |
|
7 |
118.64 |
Jan. 14, 2025 | USD 12.41 | 3.29% |
|
South Korea |
|
8 |
105.20 |
Jan. 14, 2025 | USD 10.90 | 0.42% |
|
South Korea |
|
9 |
102.58 |
Jan. 14, 2025 | USD 19.44 | 2.17% |
|
South Korea |
|
10 |
100.54 |
Jan. 14, 2025 | USD 38.12 | 0.02% |
|
South Korea |
|
11 |
85.01 |
Jan. 14, 2025 | USD 6.61 | 0.74% |
|
South Korea |
|
12 |
80.34 |
Jan. 14, 2025 | USD 61.65 | 0.74% |
|
South Korea |
|
13 |
72.00 |
Jan. 14, 2025 | USD 3.38 | 1.56% |
|
||
14 |
71.84 |
Jan. 14, 2025 | USD 83.61 | 0.82% |
|
South Korea |
|
15 |
63.08 |
Jan. 14, 2025 | USD 11.51 | 2.62% |
|
South Korea |
|
16 |
60.11 |
Jan. 14, 2025 | USD 14.77 | 4.11% |
|
South Korea |
|
17 |
60.07 |
Jan. 14, 2025 | USD 164.02 | 0.74% |
|
South Korea |
|
18 |
46.16 |
Jan. 14, 2025 | USD 107.55 | 0.48% |
|
South Korea |
|
19 |
43.46 |
Jan. 14, 2025 | USD 14.39 | 5.23% |
|
South Korea |
|
20 |
41.29 |
Jan. 14, 2025 | USD 22.81 | 2.89% |
|
South Korea |
|
21 |
35.89 |
Jan. 14, 2025 | USD 26.77 | 2.97% |
|
South Korea |
|
22 |
34.83 |
Jan. 14, 2025 | USD 1.27 | 0.36% |
|
South Korea |
|
23 |
34.69 |
Jan. 14, 2025 | USD 9.06 | 3.38% |
|
South Korea |
|
24 |
30.42 |
Jan. 14, 2025 | USD 171.86 | 2.57% |
|
South Korea |
|
25 |
25.29 |
Jan. 14, 2025 | USD 19.16 | -0.15% |
|
South Korea |
|
26 |
24.58 |
Jan. 14, 2025 | USD 6.10 | 4.23% |
|
South Korea |
|
27 |
23.66 |
Jan. 14, 2025 | USD 130.88 | -2.32% |
|
South Korea |
|
28 |
21.09 |
Jan. 14, 2025 | USD 51.70 | 7.85% |
|
South Korea |
|
29 |
20.90 |
Jan. 14, 2025 | USD 20.22 | 1.08% |
|
South Korea |
|
30 |
20.68 |
Jan. 14, 2025 | USD 12.39 | 1.63% |
|
||
31 |
19.04 |
Jan. 14, 2025 | USD 21.48 | 0.74% |
|
||
32 |
18.57 |
Jan. 14, 2025 | USD 2.17 | -0.20% |
|
South Korea |
|
33 |
18.37 |
Jan. 14, 2025 | USD 5.30 | 3.95% |
|
South Korea |
|
34 |
18.09 |
Jan. 14, 2025 | USD 1.95 | 1.81% |
|
South Korea |
|
35 |
17.93 |
Jan. 14, 2025 | USD 52.51 | 7.73% |
|
South Korea |
|
36 |
17.63 |
Jan. 14, 2025 | USD 9.13 | 6.89% |
|
South Korea |
|
37 |
17.13 |
Jan. 14, 2025 | USD 5.07 | 0.47% |
|
South Korea |
|
38 |
16.98 |
Jan. 14, 2025 | USD 49.10 | 4.21% |
|
South Korea |
|
39 |
16.71 |
Jan. 14, 2025 | USD 40.03 | 1.26% |
|
South Korea |
|
40 |
16.65 |
Jan. 14, 2025 | USD 18.31 | -0.92% |
|
South Korea |
|
41 |
16.32 |
Jan. 14, 2025 | USD 8.54 | 0.34% |
|
South Korea |
|
42 |
15.30 |
Jan. 14, 2025 | USD 1.68 | 1.98% |
|
South Korea |
|
43 |
14.88 |
Jan. 14, 2025 | USD 3.25 | 1.59% |
|
South Korea |
|
44 |
14.67 |
Jan. 14, 2025 | USD 12.37 | 2.38% |
|
South Korea |
|
45 |
13.92 |
Jan. 14, 2025 | USD 26.12 | -1.82% |
|
South Korea |
|
46 |
13.63 |
Jan. 14, 2025 | USD 17.73 | 8.68% |
|
South Korea |
|
47 |
13.13 |
Jan. 14, 2025 | USD 33.38 | 4.14% |
|
South Korea |
|
48 |
12.96 |
Jan. 14, 2025 | USD 13.26 | 1.52% |
|
South Korea |
|
49 |
12.86 |
Jan. 14, 2025 | USD 11.69 | 2.23% |
|
South Korea |
|
50 |
12.76 |
Jan. 14, 2025 | USD 6.29 | 0.85% |
|
South Korea |
The company on the KOSDAQ with the highest Price to Earnings Ratio (P/E) is Daejoo Electronic Materials Co., Ltd. (KOSDAQ: 078600.KQ) at 1,966.71.
The company on the KOSDAQ with the lowest Price to Earnings Ratio (P/E) is ALTEOGEN Inc. (KOSDAQ: 196170.KQ) at -4,288.39.
The top 10 companies on the KOSDAQ by Price to Earnings Ratio (P/E) are Daejoo Electronic Materials Co., Ltd., Seegene, Inc., Robostar Co., Ltd., TES Co., Ltd, Ecopro Co., Ltd., INSUN Environmental New Technology Co., Ltd., HFR, Inc., i-SENS, Inc., Pearl Abyss Corp. and Celltrion Pharm, Inc..
The bottom 10 companies on the KOSDAQ by Price to Earnings Ratio (P/E) are ALTEOGEN Inc., Ecopro BM. Co., Ltd., ABL Bio Inc., HLB Therapeutics Co.,Ltd., HLB Life Science Co., Ltd., Techwing, Inc., Peptron, Inc., Selvas AI Inc., NatureCell Co.,Ltd. and Wonik Ips Co., Ltd.